ID   MYLK2_HUMAN             Reviewed;         596 AA.
AC   Q9H1R3; Q569L1; Q96I84;
DT   19-OCT-2002, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   12-APR-2017, entry version 164.
DE   RecName: Full=Myosin light chain kinase 2, skeletal/cardiac muscle;
DE            Short=MLCK2;
DE            EC=2.7.11.18;
GN   Name=MYLK2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND VARIANTS CMH VAL-87 AND
RP   GLU-95.
RC   TISSUE=Skeletal muscle;
RX   PubMed=11733062; DOI=10.1016/S0092-8674(01)00586-4;
RA   Davis J.S., Hassanzadeh S., Winitsky S., Lin H., Satorius C.,
RA   Vemuri R., Aletras A.H., Wen H., Epstein N.D.;
RT   "The overall pattern of cardiac contraction depends on a spatial
RT   gradient of myosin regulatory light chain phosphorylation.";
RL   Cell 107:631-641(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Skeletal muscle;
RA   Stanchi F., Lanfranchi G.;
RT   "Full-length sequencing of 100 cDNA clones from human adult skeletal
RT   muscle.";
RL   Submitted (FEB-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 566-587 IN COMPLEX WITH
RP   CENTRIN, AND SUBUNIT.
RA   Radu L., Miron S., Durand D., Assairi L., Blouquit Y.,
RA   Charbonnier J.B.;
RT   "Structural features of the complexes formed by Scherffelia dubia
RT   centrin.";
RL   Submitted (JAN-2011) to the PDB data bank.
RN   [6]
RP   VARIANTS [LARGE SCALE ANALYSIS] VAL-117; VAL-142; ALA-144 AND ASN-324.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Implicated in the level of global muscle contraction and
CC       cardiac function. Phosphorylates a specific serine in the N-
CC       terminus of a myosin light chain. {ECO:0000269|PubMed:11733062}.
CC   -!- CATALYTIC ACTIVITY: ATP + [myosin light-chain] = ADP + [myosin
CC       light-chain] phosphate.
CC   -!- SUBUNIT: May interact with centrin. {ECO:0000269|Ref.5}.
CC   -!- INTERACTION:
CC       Q06413:MEF2C; NbExp=2; IntAct=EBI-356910, EBI-2684075;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Note=Colocalizes with
CC       phosphorylated myosin light chain (RLCP) at filaments of the
CC       myofibrils.
CC   -!- TISSUE SPECIFICITY: Heart and skeletal muscles. Increased
CC       expression in the apical tissue compared to the interventricular
CC       septal tissue.
CC   -!- DISEASE: Cardiomyopathy, familial hypertrophic (CMH) [MIM:192600]:
CC       A hereditary heart disorder characterized by ventricular
CC       hypertrophy, which is usually asymmetric and often involves the
CC       interventricular septum. The symptoms include dyspnea, syncope,
CC       collapse, palpitations, and chest pain. They can be readily
CC       provoked by exercise. The disorder has inter- and intrafamilial
CC       variability ranging from benign to malignant forms with high risk
CC       of cardiac failure and sudden cardiac death.
CC       {ECO:0000269|PubMed:11733062}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK
CC       Ser/Thr protein kinase family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF325549; AAK15494.1; -; mRNA.
DR   EMBL; AJ272502; CAC81354.1; -; mRNA.
DR   EMBL; AL160175; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC007753; AAH07753.1; -; mRNA.
DR   EMBL; BC069627; AAH69627.1; -; mRNA.
DR   EMBL; BC092413; AAH92413.1; -; mRNA.
DR   EMBL; BC127622; AAI27623.1; -; mRNA.
DR   CCDS; CCDS13191.1; -.
DR   RefSeq; NP_149109.1; NM_033118.3.
DR   UniGene; Hs.86092; -.
DR   PDB; 2LV6; Other; -; B=566-591.
DR   PDB; 3KF9; X-ray; 2.60 A; B/D=566-587.
DR   PDBsum; 2LV6; -.
DR   PDBsum; 3KF9; -.
DR   ProteinModelPortal; Q9H1R3; -.
DR   SMR; Q9H1R3; -.
DR   BioGrid; 124494; 17.
DR   IntAct; Q9H1R3; 8.
DR   MINT; MINT-1158812; -.
DR   STRING; 9606.ENSP00000365152; -.
DR   BindingDB; Q9H1R3; -.
DR   ChEMBL; CHEMBL2777; -.
DR   DrugBank; DB04825; Prenylamine.
DR   GuidetoPHARMACOLOGY; 1553; -.
DR   iPTMnet; Q9H1R3; -.
DR   PhosphoSitePlus; Q9H1R3; -.
DR   BioMuta; MYLK2; -.
DR   DMDM; 24211884; -.
DR   EPD; Q9H1R3; -.
DR   MaxQB; Q9H1R3; -.
DR   PaxDb; Q9H1R3; -.
DR   PeptideAtlas; Q9H1R3; -.
DR   PRIDE; Q9H1R3; -.
DR   DNASU; 85366; -.
DR   Ensembl; ENST00000375985; ENSP00000365152; ENSG00000101306.
DR   Ensembl; ENST00000375994; ENSP00000365162; ENSG00000101306.
DR   GeneID; 85366; -.
DR   KEGG; hsa:85366; -.
DR   UCSC; uc002wwq.3; human.
DR   CTD; 85366; -.
DR   DisGeNET; 85366; -.
DR   GeneCards; MYLK2; -.
DR   GeneReviews; MYLK2; -.
DR   HGNC; HGNC:16243; MYLK2.
DR   HPA; HPA059704; -.
DR   HPA; HPA059890; -.
DR   MalaCards; MYLK2; -.
DR   MIM; 192600; phenotype.
DR   MIM; 606566; gene.
DR   neXtProt; NX_Q9H1R3; -.
DR   OpenTargets; ENSG00000101306; -.
DR   Orphanet; 155; Familial isolated hypertrophic cardiomyopathy.
DR   PharmGKB; PA31389; -.
DR   eggNOG; KOG0032; Eukaryota.
DR   eggNOG; ENOG410XRMJ; LUCA.
DR   GeneTree; ENSGT00760000118877; -.
DR   HOGENOM; HOG000233016; -.
DR   HOVERGEN; HBG080416; -.
DR   InParanoid; Q9H1R3; -.
DR   KO; K00907; -.
DR   OMA; SNWYFDE; -.
DR   OrthoDB; EOG091G005W; -.
DR   PhylomeDB; Q9H1R3; -.
DR   TreeFam; TF314166; -.
DR   BRENDA; 2.7.11.18; 2681.
DR   SignaLink; Q9H1R3; -.
DR   SIGNOR; Q9H1R3; -.
DR   EvolutionaryTrace; Q9H1R3; -.
DR   GeneWiki; MYLK2; -.
DR   GenomeRNAi; 85366; -.
DR   PRO; PR:Q9H1R3; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   Bgee; ENSG00000101306; -.
DR   CleanEx; HS_MYLK2; -.
DR   Genevisible; Q9H1R3; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0030017; C:sarcomere; IC:BHF-UCL.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005516; F:calmodulin binding; ISS:BHF-UCL.
DR   GO; GO:0004683; F:calmodulin-dependent protein kinase activity; ISS:BHF-UCL.
DR   GO; GO:0004687; F:myosin light chain kinase activity; IDA:BHF-UCL.
DR   GO; GO:0060048; P:cardiac muscle contraction; IC:BHF-UCL.
DR   GO; GO:0055008; P:cardiac muscle tissue morphogenesis; IMP:BHF-UCL.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0007274; P:neuromuscular synaptic transmission; IEA:Ensembl.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IBA:GO_Central.
DR   GO; GO:0018107; P:peptidyl-threonine phosphorylation; IDA:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; IDA:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:UniProtKB.
DR   GO; GO:0032971; P:regulation of muscle filament sliding; IDA:BHF-UCL.
DR   GO; GO:0035914; P:skeletal muscle cell differentiation; IDA:UniProtKB.
DR   GO; GO:0014816; P:skeletal muscle satellite cell differentiation; IEA:Ensembl.
DR   GO; GO:0006941; P:striated muscle contraction; IDA:BHF-UCL.
DR   InterPro; IPR020636; Ca/CaM-dep_Ca-dep_prot_Kinase.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   PANTHER; PTHR24347; PTHR24347; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ATP-binding; Calmodulin-binding;
KW   Cardiomyopathy; Complete proteome; Cytoplasm; Disease mutation;
KW   Kinase; Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Reference proteome; Serine/threonine-protein kinase; Transferase.
FT   INIT_MET      1      1       Removed. {ECO:0000250|UniProtKB:P07313}.
FT   CHAIN         2    596       Myosin light chain kinase 2,
FT                                skeletal/cardiac muscle.
FT                                /FTId=PRO_0000086408.
FT   DOMAIN      285    540       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     291    299       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   REGION      574    586       Calmodulin-binding. {ECO:0000250}.
FT   COMPBIAS    261    268       Poly-Pro.
FT   ACT_SITE    406    406       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING     314    314       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000250|UniProtKB:P07313}.
FT   MOD_RES     143    143       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8VCR8}.
FT   MOD_RES     149    149       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8VCR8}.
FT   MOD_RES     151    151       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8VCR8}.
FT   MOD_RES     445    445       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P20689}.
FT   VARIANT      87     87       A -> V (in CMH; dbSNP:rs121908107).
FT                                {ECO:0000269|PubMed:11733062}.
FT                                /FTId=VAR_014197.
FT   VARIANT      95     95       A -> E (in CMH; dbSNP:rs121908108).
FT                                {ECO:0000269|PubMed:11733062}.
FT                                /FTId=VAR_014198.
FT   VARIANT     117    117       A -> V (in a lung neuroendocrine
FT                                carcinoma sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040860.
FT   VARIANT     142    142       G -> V (in dbSNP:rs56385445).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040861.
FT   VARIANT     144    144       P -> A (in dbSNP:rs34396614).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040862.
FT   VARIANT     324    324       K -> N (in dbSNP:rs34146416).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040863.
FT   CONFLICT    355    361       IVLFMEY -> GGVCAHS (in Ref. 4; AAH07753).
FT                                {ECO:0000305}.
FT   HELIX       567    586       {ECO:0000244|PDB:3KF9}.
SQ   SEQUENCE   596 AA;  64685 MW;  671A2B5DE9453ADE CRC64;
     MATENGAVEL GIQNPSTDKA PKGPTGERPL AAGKDPGPPD PKKAPDPPTL KKDAKAPASE
     KGDGTLAQPS TSSQGPKGEG DRGGGPAEGS AGPPAALPQQ TATPETSVKK PKAEQGASGS
     QDPGKPRVGK KAAEGQAAAR RGSPAFLHSP SCPAIISSSE KLLAKKPPSE ASELTFEGVP
     MTHSPTDPRP AKAEEGKNIL AESQKEVGEK TPGQAGQAKM QGDTSRGIEF QAVPSEKSEV
     GQALCLTARE EDCFQILDDC PPPPAPFPHR MVELRTGNVS SEFSMNSKEA LGGGKFGAVC
     TCMEKATGLK LAAKVIKKQT PKDKEMVLLE IEVMNQLNHR NLIQLYAAIE TPHEIVLFME
     YIEGGELFER IVDEDYHLTE VDTMVFVRQI CDGILFMHKM RVLHLDLKPE NILCVNTTGH
     LVKIIDFGLA RRYNPNEKLK VNFGTPEFLS PEVVNYDQIS DKTDMWSMGV ITYMLLSGLS
     PFLGDDDTET LNNVLSGNWY FDEETFEAVS DEAKDFVSNL IVKDQRARMN AAQCLAHPWL
     NNLAEKAKRC NRRLKSQILL KKYLMKRRWK KNFIAVSAAN RFKKISSSGA LMALGV
//
